Celva Bio/ Neurologic/ Evaluation process
§ 001 · Process

Slow, by
design.

The neurologic evaluation is written-first, physician-read, and unhurried. Most inquiries take two to four weeks to resolve. That time buys an honest decision, not a convenient one.

Evaluation
No fee

Written review, physician call, and written decision are included without charge.

Timeline
2–4 wks

From submission to decision. Depends on case complexity and imaging availability.

Decision
Written

You receive the physician's decision in writing, with reasons. Accept, decline, or defer.

§ 002 · Written-first

Why writing
matters.

A phone sales call is the wrong tool for neurologic cases. Written intake lets the physician read carefully, cross-check against imaging, and consult literature before any decision is framed.

It also lets you, the patient or family, put the case in your own words without being rushed. You can include what you've already tried, what you're worried about, and what a meaningful outcome would look like for your family.

Once the physician has read, then we talk. Not the reverse order.

What we ask for

Diagnosis, imaging reports, MRI disks, medication list, prior therapy trials, neurologist correspondence if available, and what a good 12-month outcome looks like from your perspective.

§ 003 · The steps

How the
weeks unfold.

Step 01

Inquiry

Short initial form. Short call with the care team, logistics only, not medical. We send the intake packet.

Day 1
Step 02

Written intake

You submit the written intake, imaging, reports, and records.

Day 3–10
Step 03

Physician review

Attending reads the case. May land as a decline here if the profile is clearly outside scope.

Day 10–15
Step 04

Call

Extended call with the physician. Discussion of rationale, realistic expectations, and questions both ways.

Day 15–20
Step 05

Written decision

Accept with a care plan. Decline with reasons and referrals where appropriate. Defer for additional information.

Day 20–28
§ 004 · Three outcomes

Every case
ends one of three ways.

Outcome 01

Accept · proceed to scheduling

Written care plan with dose, route, timing, follow-up schedule, and measured endpoints. Scheduling begins when you're ready.

Outcome 02

Decline · with reasons

Written explanation of why the case doesn't fit. Where appropriate, referrals to trials, specialists, or alternate pathways.

Outcome 03

Defer · pending information

Additional imaging, labs, or specialist evaluation requested. Decision reopens when the information is in hand.

§ 005 · Questions

Process
questions.

Q.01Is there a fee for the evaluation?
No. The written review, physician call, and written decision are included without charge. We absorb that time as part of the screening these cases deserve.
Q.02Can I skip the written intake and just do a call?
No. Written-first is non-negotiable for neurologic cases. It protects the quality of the decision. Phone-first intake leads to reflexive yesses we don't agree with.
Q.03Is the decline letter final?
A decline on current evidence doesn't always stay a decline. If circumstances change, new imaging, trial eligibility, diagnosis refinement, cases can be reopened.
Q.04What if I've already had stem cell therapy elsewhere?
Tell us. Prior therapy, what was used, and what the response was becomes part of the case. It doesn't automatically disqualify you, but it matters.
§ 007 · Start here

Begin the
written intake.

The inquiry form is short. The intake packet that follows is thorough. Allow two to four weeks for the full evaluation.

Begin intake →
Not medical advice. Neurologic candidacy undergoes extensive screening.